Health ❯ Healthcare ❯ Clinical Trials

Cancer Research

Glioblastoma Lung Cancer Survival Rates Therapeutic Innovations Prostate Cancer Personalized Medicine Melanoma Trials Pembrolizumab Car T-cell Therapy Skin Cancer Vaccines Solid Tumors Translational Oncology Daratumumab Studies Therapeutic Techniques B-cell Acute Lymphoblastic Leukemia Lymphoma Treatments Tumor Targeting Myeloma Clinical Trials Pancreatic Cancer Pediatric Oncology PCT Development Breast Cancer Targeted Therapy Immunotherapy Trials Innovative Treatments Blood Cancers HER2-positive Breast Cancer Feline Cancer Treatments Non-Small Cell Lung Cancer Phase III Trials UAE Medical Innovations Multiple Myeloma Patient Outcomes Antibody Development HER2-Mutation Therapies Small Cell Lung Cancer Cholangiocarcinoma Immunotherapy Melanoma Leukaemia Trials Glioblastoma Treatment Immunocore ECHELON-1 Trial PIK3CA Mutations in Breast Cancer Brexit Impact Case Western Reserve University

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

A peer-reviewed retrospective analysis reports large risk reductions, prompting calls for randomized confirmation.

City of Hope Completes $1.5 Billion Irvine Cancer Hospital, First Patients Arrive Dec. 1

Pluvicto Added to Standard Care Extends rPFS in PSMA-Positive Metastatic Hormone-Sensitive Prostate Cancer

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Engineered CAR-T Cells Target PD-L1 to Deliver IL-12 at Tumors, Showing Solid-Tumor Gains in Mice

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

WCLC 2025: Combination Approaches Redraw EGFR-Mutant NSCLC Care

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

UC San Diego Launches Clinical Trial of Sequenced Radiotherapy and Immunotherapy for Head and Neck Cancer

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Nagoya University Advances Eva1-Targeted CAR-T Therapy to Preclinical Safety Testing

Swiss Team Secures Innosuisse Funding to Advance Terbium-161 Lymphoma Treatment

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

CAPGLO Device Promises Rapid, Low-Cost T Cell Harvesting for CAR T Therapy